Addex Therapeutics Ltd.: Form 20-F for the period ended Dec 31, 2024
Filed with the SEC on May 15, 2025 and accepted by EDGAR at May 15, 2025, 16:01 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-01-01 to 2024-12-31 | CHF 404.1k | ifrs-full:RevenueFromContractsWithCustomers |
| Operating income | 12 months2024-01-01 to 2024-12-31 | −CHF 2.8m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2024-01-01 to 2024-12-31 | CHF 0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2024-01-01 to 2024-12-31 | CHF 7.1m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months2024-01-01 to 2024-12-31 | CHF 0.07 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2024-01-01 to 2024-12-31 | CHF 0.07 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2024-01-01 to 2024-12-31 | −CHF 5.4m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2024-01-01 to 2024-12-31 | CHF 1.3k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2024-12-31 | CHF 3.3m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2024-12-31 | CHF 3.5m | ifrs-full:CurrentAssets |
| Total assets | At period end2024-12-31 | CHF 10.7m | ifrs-full:Assets |
| Current liabilities | At period end2024-12-31 | CHF 802.1k | ifrs-full:CurrentLiabilities |
| Shareholders' equity | At period end2024-12-31 | CHF 9.7m | ifrs-full:Equity |
| Shares outstanding | At period end2024-12-31 | 128,292,969 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-25-049380. Last ingested by Listed: Nov 14, 2026, 18:51 ET. Listed shows no prices and gives no investment advice.